243 related articles for article (PubMed ID: 31652641)
1. Glycan Analysis as Biomarkers for Testicular Cancer.
Hires M; Jane E; Mego M; Chovanec M; Kasak P; Tkac J
Diagnostics (Basel); 2019 Oct; 9(4):. PubMed ID: 31652641
[TBL] [Abstract][Full Text] [Related]
2. Glycan signatures for the identification of cisplatin-resistant testicular cancer cell lines: Specific glycoprofiling of human chorionic gonadotropin (hCG).
Hires M; Jane E; Kalavska K; Chovanec M; Mego M; Kasak P; Bertok T; Tkac J
Cancer Med; 2022 Feb; 11(4):968-982. PubMed ID: 35044085
[TBL] [Abstract][Full Text] [Related]
3. The diagnostic performance of current tumour markers in surveillance for recurrent testicular cancer: A diagnostic test accuracy systematic review.
Nicholson BD; Jones NR; Protheroe A; Joseph J; Roberts NW; Van den Bruel A; Fanshawe TR
Cancer Epidemiol; 2019 Apr; 59():15-21. PubMed ID: 30658216
[TBL] [Abstract][Full Text] [Related]
4. Serum lactate dehydrogenase isoenzyme 1 and prediction of death in patients with metastatic testicular germ cell tumors.
von Eyben FE; Blaabjerg O; Hyltoft-Petersen P; Madsen EL; Amato R; Liu F; Fritsche H
Clin Chem Lab Med; 2001 Jan; 39(1):38-44. PubMed ID: 11256799
[TBL] [Abstract][Full Text] [Related]
5. Prognostic Significance of Systemic Inflammation Markers in Testicular and Penile Cancer: A Narrative Review of Current Literature.
Janicic A; Petrovic M; Zekovic M; Vasilic N; Coric V; Milojevic B; Zivkovic M; Bumbasirevic U
Life (Basel); 2023 Feb; 13(3):. PubMed ID: 36983756
[TBL] [Abstract][Full Text] [Related]
6. [Human placental alkaline phosphatase (hPLAP) is the most frequently elevated serum marker in testicular cancer].
Neumann A; Keller T; Jocham D; Doehn C
Aktuelle Urol; 2011 Sep; 42(5):311-5. PubMed ID: 21809268
[TBL] [Abstract][Full Text] [Related]
7. Alpha-fetoprotein (AFP) and human chorionic gonadotropin (HCG) in testicular germ cell tumours. A comparison of histologic and serologic occurrence of tumour markers.
Jacobsen GK
Acta Pathol Microbiol Immunol Scand A; 1983 May; 91(3):183-90. PubMed ID: 6190351
[TBL] [Abstract][Full Text] [Related]
8. Obstetrical complications associated with abnormal maternal serum markers analytes.
Gagnon A; Wilson RD;
J Obstet Gynaecol Can; 2008 Oct; 30(10):918-932. PubMed ID: 19038077
[TBL] [Abstract][Full Text] [Related]
9. Hyperglycosylated human chorionic gonadotropin in serum of testicular cancer patients.
Lempiäinen A; Hotakainen K; Blomqvist C; Alfthan H; Stenman UH
Clin Chem; 2012 Jul; 58(7):1123-9. PubMed ID: 22529110
[TBL] [Abstract][Full Text] [Related]
10. The search for biomarkers of metastatic seminoma.
Ruf CG; Khalili-Harbi N; Sachs S; Isbarn H; Wagner W; Matthies C; Meineke V; Fisch M; Chun FK; Abend M
J Urol; 2013 Sep; 190(3):1046-51. PubMed ID: 23583226
[TBL] [Abstract][Full Text] [Related]
11. Localization of alpha-fetoprotein and human chorionic gonadotropin to specific histologic types of nonseminomatous testicular cancer.
Fowler JE; Sesterhenn I; Stutzman RE; Mostofi FK
Urology; 1983 Dec; 22(6):649-54. PubMed ID: 6196899
[TBL] [Abstract][Full Text] [Related]
12. Site-specific glycan analysis of human chorionic gonadotropin beta-subunit from malignancies and pregnancy by liquid chromatography--electrospray mass spectrometry.
Valmu L; Alfthan H; Hotakainen K; Birken S; Stenman UH
Glycobiology; 2006 Dec; 16(12):1207-18. PubMed ID: 16880503
[TBL] [Abstract][Full Text] [Related]
13. Non-Coding microRNAs as Novel Potential Tumor Markers in Testicular Cancer.
Regouc M; Belge G; Lorch A; Dieckmann KP; Pichler M
Cancers (Basel); 2020 Mar; 12(3):. PubMed ID: 32235691
[TBL] [Abstract][Full Text] [Related]
14. Tumour marker concentration at the start of chemotherapy is a stronger predictor of treatment failure than marker half-life: a study in patients with disseminated non-seminomatous testicular cancer.
de Wit R; Sylvester R; Tsitsa C; de Mulder PH; Sleyfer DT; ten Bokkel Huinink WW; Kaye SB; van Oosterom AT; Boven E; Vermeylen K; Stoter G
Br J Cancer; 1997; 75(3):432-5. PubMed ID: 9020492
[TBL] [Abstract][Full Text] [Related]
15. [Tumor markers in testicular cancer].
Mann K
Urologe A; 1990 Mar; 29(2):77-86. PubMed ID: 2158684
[TBL] [Abstract][Full Text] [Related]
16. [Tumor marker diagnosis in non-seminomatous testicular tumors using human chorionic gonadotropin (HCG) and alpha fetoprotein (AFP)].
Boewer C; Nawka S; Fleck H; Uibel M; Immer U; Schmidt HE; Herzmann H; Pilgrim G; Ziegenbein R
Z Urol Nephrol; 1985 Feb; 78(2):77-86. PubMed ID: 2581393
[TBL] [Abstract][Full Text] [Related]
17. Human chorionic gonadotropin (HCG) and alpha-fetoprotein (AFP) in sera and tumor cells of patients with testicular seminoma: a prospective study.
Javadpour N; McIntire KR; Waldmann TA
Cancer; 1978 Dec; 42(6):2768-72. PubMed ID: 83187
[TBL] [Abstract][Full Text] [Related]
18. Lactic dehydrogenase in the monitoring and prognosis of testicular cancer.
Lippert MC; Javadpour N
Cancer; 1981 Nov; 48(10):2274-8. PubMed ID: 6170417
[TBL] [Abstract][Full Text] [Related]
19. Cellular localization of alpha-fetoprotein and human chorionic gonadotropin in germ cell tumors of the testis using and indirect immunoperoxidase technique.
Kurman RJ; Scardino PT; McIntire KR; Waldmann TA; Javadpour N
Cancer; 1977 Nov; 40(5):2136-51. PubMed ID: 72596
[TBL] [Abstract][Full Text] [Related]
20. Detection of AFP and HCG in metastatic testicular cancer after treatment with chemotherapy or radiation therapy.
Fowler JE; Sesterhenn IA; Mostofi FK
Urology; 1989 Jan; 33(1):74-7. PubMed ID: 2463705
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
